Sign in
4

Changes in Ownership

Foghorn Therapeutics Inc. Filed Acc 0001562180-24-000609

Options or other derivatives

  • Chief Medical Officer acquired 60,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Cardama Alfonso Quintas Chief Medical Officer 2024-01-24 Grant or award · Stock Option (right to buy) +60,000 $3.06 $183,600 60,000 D
Loading xslF345X05/primarydocument.xml…